Logo_AIHTA
  • English
            Menu_button
                          • Synopsis of completed research projects
                                            Video
                                            Video: What is HTA?    
                                            • Home
                                            • Research Projects
                                            • Synopsis of completed research projects
                                            • Update PET/PET-CT: evidence for need based planning in oncological indications

                                            Update PET/PET-CT: evidence for need based planning in oncological indications

                                            Fotolia-40910836-von-videodoctor2

                                            Project leaders: /page/claudia-wild/en

                                            Project team: /page/ozren-sehic/en, /page/daniela-auinger/en

                                            Duration: December 2022 – April 2023





                                            Hardly any other medical technology has been evaluated as often in Western countries as positron emission tomography (PET/PET-CT). The aim of the update presented here (of the 2015, 2018 and 2020 reports) is to identify oncological indications for which the use of PET/PET-CT is recommended or explicitly not recommended by relevant professional societies and in evidence-based guidelines. For this purpose, a comprehensive hand search of guideline databases, websites and databases of national and supranational professional societies is conducted.

                                            • Update 2023: AIHTA Policy Brief No. 003/3. Update
                                            • Update 2020: AIHTA Policy Brief No. 003/2. Update
                                            • Update 2018: LBI-HTA Project report No. 77/ Update 2018
                                            • 2015: LBI-HTA Projektbericht No. 77

                                            Contact: Claudia Wild

                                                                                                                Netzwerk
                                                                                                                • Eunethta
                                                                                                                • Ebm
                                                                                                                • Inahta
                                                                                                                • Dexhelpp
                                                                                                                Shareholder
                                                                                                                • Bmfg
                                                                                                                • Sv
                                                                                                                • Wgfond
                                                                                                                • Noe
                                                                                                                • Ooghfond
                                                                                                                • Ghls
                                                                                                                • Tirol
                                                                                                                • Vorarlberg
                                                                                                                • Kghfond
                                                                                                                • Ghpf
                                                                                                                • Burgef
                                                                                                                          © 2025 HTA Austria - Austrian Institute for Health Technology Assessment GmbH. Alle Rechte vorbehalten.
                                                                                                                          • Log in